Home › Prostate Cancer › NCT00949819
Active Surveillance for Cancer of the Prostate (ASCaP)
The UCLA ASCAP Project is an Observational, Longitudinal, and Open-ended Study Aimed at Establishing a Structured Program of Non-interventional Follow-up for Localized Prostate Cancer.
Who can join
Ages 30 to 85 · Men
Full eligibility criteria
Inclusion Criteria: 1. Histologically confirmed adenocarcinoma of the prostate. 2. Clinically localized prostate cancer: T1-2, NX or N0, MX or M0. 3. No previous treatment for prostate cancer (including hormonal therapy, radiation therapy, surgery, or chemotherapy). 4. Patient has elected Active Surveillance as preferred management plan for prostate cancer. 5. Patient consent has been obtained according to local Institutional Review Board . 6. Patient is accessible and compliant for follow-up. Exclusion Criteria: 1. Unwillingness or inability to undergo serial prostate biopsy. 2. Overall life expectancy less than 2 years 3. Advanced prostate cancer
About the study
Active Surveillance (A.S.) of prostate cancer (CaP) is the systematic monitoring of men with low-risk, localized lesions, with curative treatment of those whose tumors show substantial progression. A.S. is different from Watchful Waiting (W.W.), which is the palliative treatment of men with progressive prostate cancer.
What is being tested
- Active surveillance (other)
Sponsor: Jonsson Comprehensive Cancer Center · Participants: 462 · Started: Jul 4, 2009
Contact the study team
- Malu Macairan · Phone: (310) 794-3566
- Leonard S Marks, M.D. · Phone: (310) 794-3070
Official record on ClinicalTrials.gov — NCT00949819
Locations in the U.S.
| California | University of California Los Angeles, Los Angeles |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.